(Q42157592)

English

The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer.

scientific article

Statements

The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. (English)
1 January 1990
351-356

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit